Brain aging in adults with PKU
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how the brain ages in adults with PKU. It uses an MRI scan to compare brain changes between people with PKU and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have PKU and be 18 years or older.
- You started a low-phenylalanine diet within your first month of life.
- You have been following that diet regularly for the past 6 months.
- Your blood phenylalanine level has stayed below 1600 µmol/L in the last 6 months.
- You must not be pregnant or breastfeeding.
- You must be able to have an MRI (no metal implants, pacemaker, or braces that interfere).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) cope with daily life, emotions, and relationships, with input from a relative who lives with them. The goal is to better understand the challenges so care can be improved.
This trial tests an experimental medication taken as a pill to see if it can help people with PKU manage their condition. The study will check if the pill is safe and how it affects blood phenylalanine levels.
This study tests a new medicine called JNT-517 for people with phenylketonuria (PKU) over a long period. It aims to see if the drug can help manage PKU safely and effectively.
This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.
Hear when a new Phenylketonuria (PKU) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.